Conference Home | Program | Registration | Hotel

Innovation Panel: Harnessing an Innovative Ecosystem 

Intermountain Healthcare has been focusing on the power of collaboration for many years.  Over the past couple of years Intermountain has been partnering with Velano Vascular and Tissue Analytics to innovate around blood draws and how it manages patient wounds.  This panel will share the lessons learned and the approach that has been used to lead to the successful proof of concepts, pilots, and eventual enterprise contracts that resulted with Velano Vascular and Tissue Analytics. 

Panelists
Tettlebach.jpg
William H. Tettelbach, MD

Since returning to Utah in 2010, Dr. Tettelbach has served as an active member of the Intermountain Healthcare Infection Control Guidance Council and has been involved in the development of institutional policies that have resulted in a system-wide reduction in central line associated blood stream infections and the creation of an antimicrobial stewardship program. He co-chairs the Skin & Wound Care Committee, a system-wide decision rights body that has had a positive clinical and financial impact on Intermountain Healthcare by reducing the number of SKUs and standardizing dressing within the supply chain. In 2013 he established a new Undersea and Hyperbaric Medicine Fellowship at Intermountain Healthcare through a cooperative agreement with Duke University. In 2015 he fashioned a business case for the development of a wound care clinical service that led to the establishment of the Wound Care & Hyperbaric Medicine clinical service line. Successfully achieving the 2016 Board Goal of a 20% reduction in hospital acquired stage 2 through stage 4 pressure ulcers would not have been possible without the operational leadership provided by the newly established Wound Care & Hyperbaric Medicine clinical service line. Additionally, in 2015 he also proposed and is currently directing a telehealth wound care outreach program intended to improve wound related outcomes in the rural hospital and homecare settings. He is a member of the Physician Advisory Council at LDS Hospital. Under his medical directorship wound care at Intermountain Healthcare, both inpatient and outpatient, has continued to expand its outreach while positively impacting patient outcomes and increasing collaboration across multiple specialties. Since early 2016, Dr. Tettelbach has been collaborating with the Transformation Lab as their clinic champion for development and implementation of Tissue Analytics wound measuring & monitoring application. Once integrated into iCentra the Tissue Analytics application will standardize how wounds are documented across the entire enterprise system as well as create a new wound database.

Cassy Duffin-Weeks, MBA, RN

Nurse Director Children’s Surgical Unit and Wound Team

Stone.jpg
Eric M. Stone, EdM, MBA

Eric M. Stone is the Chief Executive Officer and co-founder of Velano Vascular. A patient advocate and serial healthcare entrepreneur, Stone currently serves as National Trustee and a Committee Chair of the Crohn’s and Colitis Foundation. Prior to Velano, he served as Vice President of Sales and Marketing for Molecular Health, and earlier in his career launched a series of pioneering interventional cardiology devices for Abbott while based in Brussels, Belgium and California. Stone was a founding member of Model Nʼs (NYSE: MODN) Life Sciences division, where he led marketing and business development. Stone began his career in Marketing with Trilogy Software, and has since co-founded social sector programs at Harvard and Wharton. He served for a decade on Harvard Universityʼs Alumni Association (HAA) Board of Directors. Stone is a Director of Vigilant Biosciences and an Advisor to numerous healthcare upstarts. Stone received an MBA from The Wharton School, a Masterʼs from Harvard University, and a BA from the University of Pennsylvania. He lives with his wife and children in San Francisco, California.

Brat.jpg
Gabriel A. Brat, MD
Gabriel Brat is a trauma surgeon and bioinformaticist at Harvard Medical School and Beth Israel Deaconess Medical Center. He is also the co-founder of Tissue Analytics, a platform that leverages machine learning and computer vision to transform wound care. This integrated application now boasts over 150 enterprise customers and integrations with several major electronic medical record systems. He is passionate about the intersection of surgical innovation and digital health and has published and patented numerous mechanical and digital tool to improve surgical outcomes. He specializes in projects that apply predictive and unsupervised classification methods to traditional databases and novel sensor data. He also teaches courses in health IT innovation at the medical school and mentors and advises healthcare and digital startups. Gabriel has an undergraduate degree in bioengineering and a graduate degree in public health and biostatistics from the London School of Hygiene and Tropical Medicine. He completed his medical training at Stanford University and his surgical residency at Johns Hopkins Hospital.
Dunn.jpg
Todd Dunn
Todd Dunn is the Director of Innovation in Information Systems for Intermountain Healthcare. He currently leads Intermountain’s Healthcare Transformation Lab. His passion is influencing the strategy, mindset, and toolset that enables effective innovation. His purpose is innovating to help people. Todd often spends his personal time advising startups and working with early stage companies. He was invited by Alex Osterwalder to be an exclusive pre-reader and contributor to Alex’s most recent book, Value Proposition Design. Todd is the author of “The Seven Deadline Healthcare Startups Sins” on Steve Blank’s website. Todd’s innovative program called “Design for People” is highlighted in Clayton Christensen’s book, Competing Against Luck.